An international public-private consortium, set up to build the most detailed map of human genetic variation to date, has announced the completion of three pilot projects.

In the biggest sign yet that the era of blockbuster drug is drawing to a close, Pfizer this week announced the creation of a new research unit focused on rare diseases.